Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02679131
Title To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment.
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Spectrum Pharmaceuticals, Inc
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Innovative Clinical Research Institute Whittier California 90603 United States Details
Gabrail Cancer Center Research Canton Ohio 44718 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field